BECTON DICKINSON & CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BECTON DICKINSON & CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $21.84B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $20.18B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $19.37B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $18.87B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $19.13B | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | $4.78B | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | $3.86B | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | $4.25B | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | $4.23B | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | $4.58B | Nov 25, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $3.17B | Nov 22, 2017 |
| FY2017 | Jun 30, 2017 | $3.04B | Nov 22, 2017 |
| FY2017 | Mar 31, 2017 | $2.97B | Nov 22, 2017 |
| FY2017 | Dec 31, 2016 | $2.92B | Nov 22, 2017 |
| FY2017 | Sep 30, 2016 | $3.23B | Nov 22, 2017 |
| FY2017 | Jun 30, 2016 | $3.20B | Nov 22, 2017 |
| FY2017 | Mar 31, 2016 | $3.07B | Nov 22, 2017 |
| FY2017 | Dec 31, 2015 | $2.99B | Nov 22, 2017 |
| FY2016 | Sep 30, 2015 | $3.06B | Nov 23, 2016 |
| FY2016 | Jun 30, 2015 | $3.12B | Nov 23, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Sep 30, 2020 | $2.21B | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | $1.66B | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | $1.73B | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | $1.98B | Nov 25, 2020 |
| FY2019 | Sep 30, 2019 | $2.27B | Nov 27, 2019 |
| FY2019 | Jun 30, 2019 | $2.07B | Nov 27, 2019 |
| FY2019 | Mar 31, 2019 | $1.97B | Nov 27, 2019 |
| FY2019 | Dec 31, 2018 | $1.97B | Nov 27, 2019 |
| FY2018 | Sep 30, 2018 | $2.09B | Nov 21, 2018 |
| FY2018 | Jun 30, 2018 | $2.02B | Nov 21, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.68B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $1.71B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $1.48B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $1.78B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $2.09B | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | $128.00M | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | $286.00M | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | $183.00M | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | $278.00M | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | $163.00M | Nov 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.58B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $2.40B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $2.11B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $2.28B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $2.25B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $912.00M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $1.76B | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $1.51B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $1.52B | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $1.43B | Nov 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.27B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $1.19B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $1.24B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $1.26B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $1.28B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $1.04B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $1.06B | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $1.00B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $770.00M | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $828.00M | Nov 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $5.28B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $4.86B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $4.72B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $4.71B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $4.72B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $4.19B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $4.33B | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $4.02B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $2.91B | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $3.01B | Nov 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Sep 30, 2021 | $4.65B | Nov 24, 2021 |
| FY2021 | Sep 30, 2020 | $3.54B | Nov 24, 2021 |
| FY2021 | Sep 30, 2019 | $3.33B | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $2.87B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $2.55B | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $2.56B | Nov 21, 2018 |
| FY2017 | Sep 30, 2015 | $1.73B | Nov 22, 2017 |
| FY2016 | Sep 30, 2014 | $1.75B | Nov 23, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $760.00M | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $725.00M | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $874.00M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $973.00M | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $1.19B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $769.00M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $957.00M | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $895.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $727.00M | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $693.00M | Nov 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $55.33B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $57.29B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $52.78B | Nov 27, 2024 |
| FY2023 | Sep 30, 2022 | $52.93B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $53.87B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $54.01B | Nov 24, 2021 |
| FY2020 | Sep 30, 2019 | $51.77B | Nov 25, 2020 |
| FY2020 | Sep 30, 2018 | $53.90B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $37.73B | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $25.59B | Nov 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $25.39B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $25.89B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $25.80B | Nov 27, 2024 |
| FY2023 | Sep 30, 2022 | $25.28B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $23.68B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $23.77B | Nov 24, 2021 |
| FY2020 | Sep 30, 2019 | $21.08B | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | $20.99B | Nov 27, 2019 |
| FY2018 | Sep 30, 2017 | $12.95B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $7.63B | Nov 22, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $26.61B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $26.47B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $24.52B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $24.62B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $23.89B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $23.60B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $23.38B | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $23.60B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $7.56B | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $7.42B | Nov 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $16.62B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $16.14B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $15.54B | Nov 27, 2024 |
| FY2023 | Sep 30, 2022 | $15.16B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $13.83B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $12.79B | Nov 24, 2021 |
| FY2020 | Sep 30, 2019 | $12.91B | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | $12.60B | Nov 27, 2019 |
| FY2018 | Sep 30, 2017 | $13.11B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $12.73B | Nov 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $641.00M | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $1.72B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $1.42B | Nov 27, 2024 |
| FY2023 | Sep 30, 2022 | $1.01B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $2.28B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $2.83B | Nov 24, 2021 |
| FY2020 | Sep 30, 2019 | $536.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | $1.14B | Nov 27, 2019 |
| FY2018 | Sep 30, 2017 | $14.18B | Nov 21, 2018 |
| FY2018 | Sep 30, 2016 | $1.54B | Nov 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 5 | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | 5 | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | 4 | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | 5 | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | 6 | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 5 | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | 5 | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | 4 | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | 5 | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | 6 | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 25, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.20B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $1.10B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $1.11B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $1.08B | Nov 27, 2024 |
| FY2023 | Sep 30, 2021 | $1.05B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $1.03B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $984.00M | Nov 24, 2021 |
| FY2020 | Sep 30, 2018 | $927.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $677.00M | Nov 27, 2019 |
| FY2018 | Sep 30, 2016 | $562.00M | Nov 21, 2018 |